<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30089770</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1643-3750</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>24</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>09</Day>                    </PubDate>                </JournalIssue>                <Title>Medical science monitor : international medical journal of experimental and clinical research</Title>                <ISOAbbreviation>Med. Sci. Monit.</ISOAbbreviation>            </Journal>            <ArticleTitle>Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.</ArticleTitle>            <Pagination>                <MedlinePgn>5528-5532</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.12659/MSM.910108</ELocationID>            <Abstract>                <AbstractText>BACKGROUND Breast cancer is a malignant tumor derived from breast gland epithelium. The screening and early diagnosis of breast cancer in high-risk populations can effectively suppress its threat to women's health and improve treatment efficiency, and thus has critical importance. Using various evaluation models, the present study evaluated cancer risk in 35-69-year-old women, and the usefulness of models in breast cancer prevention was compared. MATERIAL AND METHODS A total of 150 infiltrative breast cancer patients who were diagnosed with breast cancer at our hospital were recruited, along with 130 healthy women as the control group. A retrospective study was performed to collect information. The 5-year risk of breast cancer was evaluated using the Gail and Tyrer-Cuzick models. Diagnostic results were analyzed to plot ROC curves for comparing the value for screening between Gail and Tyrer-Cuzick models. RESULTS The Gail model has 53.33% sensitivity and 77.69% specificity, with 73.39% positive prediction value, 59.06% negative prediction value, 64.64% accuracy, and 0.31 Jordon index. The Tyrer-Cuzick model had 66.00% sensitivity, 86.92% specificity, 85.34% positive prediction value, 68.90% negative prediction value, 75.71% accuracy, and 0.53 Jordon index. The area under the curve (AUC) was 0.665 for the Gail model (95% CI: 0.629~0.701) and 0.786 for the Tyrer-Cuzick model (95% CI: 0.757~0.815). CONCLUSIONS Both Gail model and Tyrer-Cuzick models can be used to evaluate breast cancer risk. The Gail model has relatively lower accuracy in evaluating breast cancer risk in Jiangxi province of China and the Tyrer-Cuzick model had relatively higher accuracy.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Le</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Galactophore, Affiliated Jiujiang Hospital of Nanchang University, Jiujiang, Jiangxi, China (mainland).</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jie</LastName>                    <ForeName>Zhigang</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland).</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>Shengxi</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Galactophore, Affiliated Jiujiang Hospital of Nanchang University, Jiujiang, Jiangxi, China (mainland).</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Liqun</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Galactophore, Affiliated Jiujiang Hospital of Nanchang University, Jiujiang, Jiangxi, China (mainland).</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>Xiangqu</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Galactophore, Affiliated Jiujiang Hospital of Nanchang University, Jiujiang, Jiangxi, China (mainland).</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>09</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Med Sci Monit</MedlineTA>            <NlmUniqueID>9609063</NlmUniqueID>            <ISSNLinking>1234-1010</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2018 May;24(3):441-443</RefSource>                <PMID Version="1">29139588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Oncol Clin N Am. 2014 Jul;23(3):409-22</RefSource>                <PMID Version="1">24882341</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prog Mol Biol Transl Sci. 2017;151:1-32</RefSource>                <PMID Version="1">29096890</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2017 Dec;37(12):7057-7062</RefSource>                <PMID Version="1">29187495</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2015 Dec 01;17(1):147</RefSource>                <PMID Version="1">26627479</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Mar 7;8(10):16939-16950</RefSource>                <PMID Version="1">28199975</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Comput Methods Programs Biomed. 2015 Mar;118(3):280-97</RefSource>                <PMID Version="1">25697987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2014 Oct 08;16(5):451</RefSource>                <PMID Version="1">25292294</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2016;17(S3):43-6</RefSource>                <PMID Version="1">27165206</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Obstet Gynecol. 2016 Dec;59(4):651-672</RefSource>                <PMID Version="1">27681694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 May;115(2):381-90</RefSource>                <PMID Version="1">18516672</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Women Health. 2012;52(4):391-402</RefSource>                <PMID Version="1">22591234</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource>                <PMID Version="1">25651787</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Thorac Cancer. 2017 May;8(3):214-218</RefSource>                <PMID Version="1">28296260</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. ;18(7):1977-1983</RefSource>                <PMID Version="1">28749635</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2015;16(1):303-6</RefSource>                <PMID Version="1">25640369</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Minerva Ginecol. 2015 Aug;67(4):335-52</RefSource>                <PMID Version="1">25668503</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2016 Jul;158(1):67-77</RefSource>                <PMID Version="1">27287781</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2016;17(8):3759-62</RefSource>                <PMID Version="1">27644613</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Aug 1;28(22):3591-6</RefSource>                <PMID Version="1">20606088</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2018 May;24(3):426-428</RefSource>                <PMID Version="1">29193600</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30089770</ArticleId>            <ArticleId IdType="pii">910108</ArticleId>            <ArticleId IdType="doi">10.12659/MSM.910108</ArticleId>            <ArticleId IdType="pmc">PMC6097135</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>